AbleTo acquired Joyable, a provider of virtual therapy services for people who can’t get access to a therapist in person, to improve and bulk up their behavioral health technology platform.
Cityblock Health, a Brooklyn-based technology-driven healthcare company that unites primary care, behavioral health care, and social services—started servingEmblemHealth members in Brooklyn in 2018 and has recently teamed up withConnectiCare to improve community health in the greater Waterbury, Connecticut area. They also recently announced a partnership with Blue Cross and Blue Shield of North Carolina, where they will enter North Carolina in late 2019. Cityblock Health is growing fast and hiring across clinical and operations roles, learn more about career opportunities at Cityblock Health.
Crossix launched DIFA TV™, a television measurement platform, to help healthcare brands understand how effectively their national TV campaigns are reaching a relevant health audience.
CUNY SPH, CUNY Graduate School of Public Health and Health Policy Dean, Dr. Ayman El-Mohandes, announced dramatic improvement in ranking with US News and World Report. CUNY SPH is now ranked 23rd nationally and the number one public school for public health in New York City, New York State and the tristate region.
Decision Resources Group (DRG) has launched a bi-weekly podcast, Access to Insights. The show explores current issues and news impacting global market access for drug therapies and medical devices. Listen and subscribe on Spotify,iTunes and Google Play.
GoMo Health has rereleased their white paper that details a program created to transform mental health community services. The paper also outlines BehavioralRx®, the behavioral and cognitive science used to implement it. Learn how the program measured a 40.9% increase in participant retention, translating into a $162,529 annual revenue increase.
Healthagen and Welldoc, in collaboration with LifeScan Inc., announced details of a study to evaluate the use and potential health benefits of OneTouch Reveal® Plus.The mobile and web coaching tool is for adults with type 2 diabetes. The study will evaluate changes in specific health outcomes among individuals who participate in the tool’s tailored virtual coaching and engagement.
Healthix announced that it has achieved HITRUST CSF® Certification and HITRUST Certification of the NIST Cybersecurity Framework to Manage Risk, Improve Security Posture and Meet Compliance Requirements, placing them in an elite group of organizations worldwide that have earned this certification. They also announced the hiring of a new CEO and President, Todd M. Rogow.
PatientPoint® announced a new collaboration with the American Medical Association (AMA) aimed at reaching and activating patients at the point of care to help prevent type 2 diabetes and cardiovascular disease. Using PatientPoint technology offered in nearly 6,500 physician practices across the country, PatientPoint will provide patients and their physicians with AMA-developed education to help identify the risks for type 2 diabetes and cardiovascular disease and take action to prevent the onset of both diseases. The patient engagement leader also recently named tech veteran Wes Staggs as its first-ever EVP of Customer Success. Staggs will oversee multiple PatientPoint teams charged with delivering a best-in-industry experience to the more than 51,000 physician offices and 1,000 hospitals systems leveraging PatientPoint solutions.
PulsePoint published an article Can Femtech Deliver Radically Personalized Care to Women in a Privacy Safe Way?, that examines how technology allows us to take data from a human scale to a digital scale. But in today’s digital era, FemTech apps tracking the most sensitive information such as the female menstrual cycle and fertility window present concerns around data privacy and data control.
T3 Advisors, a real estate firm focused solely on serving technology and life science companies, is hiring a brokerage team lead. For more information please contact firstname.lastname@example.org.
TeloChain has been selected by the Houston WBENC Summit to present their Accrual Acceleration Services. TeloChain helps phase 2-4 clinical trials stay on plan by using data, analytics, and technology to accrue subjects faster. The company can work on new trials or rescue ongoing trials that are struggling to meet their enrollment targets.